Navigation Links
Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences
Date:7/16/2009

y will have the right to promote the fixed-dose combination product to healthcare professionals in all countries except Japan and the access countries. Gilead will assume the lead role in manufacturing, registration and, subject to regulatory approval, commercialization of the fixed-dose combination of TMC278 and Truvada throughout the territory.

Tibotec and Gilead are committed to working together to make the fixed-dose combination of TMC278 and Truvada available in the developing world and will work towards a separate agreement for these countries.

About TMC278

TMC278 is an investigational non-nucleoside reverse transcriptase inhibitor, and the safety and efficacy of it, in combination with other antiretroviral agents, has not been established. Two major phase III trials for TMC278 are currently being conducted in the United States, Canada, Africa, Asia, Europe and South America.

About Tibotec Pharmaceuticals

Tibotec Pharmaceuticals, based in Cork, Ireland, is a pharmaceutical research and development company. The Company's main research and development facilities are in Mechelen, Belgium with offices in Yardley, PA. Tibotec is dedicated to the discovery and development of innovative HIV/AIDS drugs and anti-infectives for diseases of high unmet medical need.

Tibotec Pharmaceuticals is a subsidiary of Johnson & Johnson.

Forward-Looking Statement

This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Tibotec's expectations and projections. Risks and uncertainties include general in
'/>"/>

SOURCE Tibotec Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine
2. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
3. Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008
4. Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
5. Tibotec Data Presented at ICAAC and HIV9 Follow Key Regulatory Approvals for Anti-HIV Compounds
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Diseases largely eradicated in the United States ... declared eliminated in 2000, yet the CDC reports 593 ... incidence in 20 years. In July, California,s ... problem of "epidemic proportions." Across ... preventable diseases—in part because some parents (more than 10 ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "Global Multiple Sclerosis Drugs Market 2014-2018" report ... a chronic, inflammatory medical condition that results in demyelination, ... because of an abnormal response by the immune system, ... It is a potentially debilitating disease in which the ...
(Date:8/29/2014)... Calif. , Aug. 29, 2014  Pacific Medical ... its new website design . The main website, ... that showcases the company,s new services and content relevant ... implementing a new streamlined design, viewers can now better ... for health care practices and create a more visible ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3PMDS Announces New Website 2
... , NEW YORK, Nov. ... report is available in its catalogue: , United ... , http://www.reportlinker.com/p0158733/United-States-Dental-Devices-Market-Analysis-and-Forecasts-to-2015.html , United States Dental ... Summary , This report is an essential source ...
... , WALTHAM, Mass., Nov. 25 According ... market intelligence, the nearly $3 billion US market for trauma fixation ... years despite the recent economic slowdown. MRG,s US Markets for ... will remain highly dynamic over the next five years, with competitors ...
Cached Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3
(Date:8/31/2014)... 2014 Connexion Point, a leader in contact ... Magazine’s 2014 Fast 50, a ranking of the state’s fastest ... honored be in the top ten in the Utah Business ... a privately held company in one of the fastest growing ... list is an important achievement.” , Connexion Point has also ...
(Date:8/31/2014)... Evergreen, CO (PRWEB) August 31, 2014 ... has released award winning, “Simplicity & Sophistication: Short ... written and narrated by Dr. James W. Jackson ... & Sophistication,” Dr. Jackson compresses his vast ... nearly four decades into over 150 countries on behalf ...
(Date:8/31/2014)... With the NCAA set to undergo significant change, ... with Yale University Associate Athletic Director Steve Conn to ... ensuring student-athlete experience that is consistent with the University’s ... of key factors that contribute to a positive sports ... creating this culture seems simple at first. “The athletes ...
(Date:8/31/2014)... Sunday 31 August 2014: Wine only protects against cardiovascular ... from the In Vino Veritas (IVV) study presented at ... Czech Republic. , Professor Taborsky said: "This is the ... white wine on markers of atherosclerosis (1) in people ... that moderate wine drinking was only protective in people ...
(Date:8/30/2014)... Saturday 30 August 2014: A new method to ... defibrillators (AEDs) was presented at ESC Congress today by ... method, Paris needs 350 AEDs located in public places ... (OHCA). , Dr Dahan said: "Out of hospital cardiac ... annual incidence ranging between 50 and 100 per 100 ...
Breaking Medicine News(10 mins):Health News:Connexion Point Named Utah Business Magazine’s Top 10 Fastest Growing Companies in Utah 2Health News:Brook Forest Voices Announces End of Summer Release! Dr. James Jackson’s, “Simplicity & Sophistication” Audiobook 2Health News:Yale University’s Steve Conn Discusses NCAA Football, Student-Athlete Experience, & Social Media SCI Talk Interview 2Health News:Yale University’s Steve Conn Discusses NCAA Football, Student-Athlete Experience, & Social Media SCI Talk Interview 3Health News:Wine only protects against CVD in people who exercise 2Health News:New method predicts optimal number and location of AEDs 2
... Physicians could do a much better job of communicating critical ... their patients, a new UCLA study has found//. ,The ... the Archives of Internal Medicine, found that in too many ... of a medication, potential adverse side effects or even the ...
... treatment in multiple sites of care may now be able ... to a study that will appear in the Sept. 25 ... was led by Eric Coleman, MD, an associate professor at ... School of Medicine, and conducted through its Division of Health ...
... statin medications reduces death and cardiovascular events for ... acute heart events//, according to an analysis. ... clearly been shown to benefit patients with cardiovascular ... However, it is less clear whether these drugs ...
... to vanquish the big time killer AIDS/ HIV infection ... spearheaded// by Dr Benigno Rodriguez M.D and his extensive ... have presented their latest findings in the current issue ... have been questioned by the latest findings, which contest ...
... announced that they have finished the preliminary work in understanding ... far from complete, but it is designed to act as ... was led by researchers at the National Institute of Aging ... The data were derived from blood samples of 267 people ...
... drugs after researchers warned that some of them ... ,The new data, culled from 140,000 patients, ... attack risk. ,The European Medicines Agency ... ibuprofen, indomethacin, ketoprofen, ketorolac, meloxicam, nabumetone, naproxen, nimesulide ...
Cached Medicine News:Health News:Physician Communication Spotty When Prescribing Medications 2Health News:'Health Care Coaches' Can Help Reduce Patient Bills, Rehospitalization 2Health News:Early Statin Therapy for Patients Reduces Death, Cardiovascular Events 2Health News:Parkinson's Disease And Genetics 2
Straight shafts with extra fine pointed tips and 6mm tying platform. Smooth handle with dull finish/...
... utilizes a small-cone design and Placido ... complete, shadow-free representation of the corneal ... that includes the topographer, PC, software, ... enables quick and easy access to ...
The Maverick Over-The-Wire balloon catheter delivers a new level of performance to meet the changing demands of interventional cardiology....
... lighted dials to make it easier and ... darkened setting of the exam room. Put ... lights off throughout the entire process. The ... and cylinder axis scales that are easier ...
Medicine Products: